How the molecular weight affects the in vivo fate of exogenous hyaluronan delivered intravenously: A stable-isotope labelling strategy
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F21%3A00542790" target="_blank" >RIV/68081707:_____/21:00542790 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00159816:_____/21:00075076 RIV/61989592:15310/21:73609606 RIV/00216224:14310/21:00121603
Výsledek na webu
<a href="https://reader.elsevier.com/reader/sd/pii/S0144861721003143?token=3B1E30F1EFFA8B688701DCC15BDDC999A5E187E791E15A519C7A4D380A7A798486099FF4C0AB22482C63D972D480C238&originRegion=eu-west-1&originCreation=20210528071650" target="_blank" >https://reader.elsevier.com/reader/sd/pii/S0144861721003143?token=3B1E30F1EFFA8B688701DCC15BDDC999A5E187E791E15A519C7A4D380A7A798486099FF4C0AB22482C63D972D480C238&originRegion=eu-west-1&originCreation=20210528071650</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.carbpol.2021.117927" target="_blank" >10.1016/j.carbpol.2021.117927</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
How the molecular weight affects the in vivo fate of exogenous hyaluronan delivered intravenously: A stable-isotope labelling strategy
Popis výsledku v původním jazyce
There is inconsistent information regarding the size effects of exogenously given hyaluronan on its in vivo fate. The data are often biased by the poor quality of hyaluronan and non-ideal labelling strategies used for resolving exogenous/endogenous hyaluronan, which only monitor the label and not hyaluronan itself. To overcome these drawbacks and establish the pharmacokinetics of intravenous hyaluronan in relation to its Mw, 13C-labelled HA of five Mws from 13.6?1562 kDa was prepared and administered to mice at doses 25-50 mg kg?1. The elimination efficiency increased with decreasing Mw. Low Mw hyaluronan was rapidly eliminated as small hyaluronan fragments in urine, while high Mw hyaluronan exhibited saturable kinetics and complete metabolization within 48 h. All tested Mws exhibited a similar uptake by liver cells and metabolization into activated sugars. 13Clabelling combined with LC?MS provides an excellent approach to elucidating in vivo fate and biological activities of hyaluronan.
Název v anglickém jazyce
How the molecular weight affects the in vivo fate of exogenous hyaluronan delivered intravenously: A stable-isotope labelling strategy
Popis výsledku anglicky
There is inconsistent information regarding the size effects of exogenously given hyaluronan on its in vivo fate. The data are often biased by the poor quality of hyaluronan and non-ideal labelling strategies used for resolving exogenous/endogenous hyaluronan, which only monitor the label and not hyaluronan itself. To overcome these drawbacks and establish the pharmacokinetics of intravenous hyaluronan in relation to its Mw, 13C-labelled HA of five Mws from 13.6?1562 kDa was prepared and administered to mice at doses 25-50 mg kg?1. The elimination efficiency increased with decreasing Mw. Low Mw hyaluronan was rapidly eliminated as small hyaluronan fragments in urine, while high Mw hyaluronan exhibited saturable kinetics and complete metabolization within 48 h. All tested Mws exhibited a similar uptake by liver cells and metabolization into activated sugars. 13Clabelling combined with LC?MS provides an excellent approach to elucidating in vivo fate and biological activities of hyaluronan.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10401 - Organic chemistry
Návaznosti výsledku
Projekt
<a href="/cs/project/EF16_026%2F0008451" target="_blank" >EF16_026/0008451: Inženýrství nových biomateriálů a biofarmak pro diagnózu a léčbu cerebrovaskulárních a neurodegenerativních onemocnění</a><br>
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2021
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Carbohydrate Polymers
ISSN
0144-8617
e-ISSN
1879-1344
Svazek periodika
263
Číslo periodika v rámci svazku
JUL 1 2021
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
10
Strana od-do
117927
Kód UT WoS článku
000640429500006
EID výsledku v databázi Scopus
2-s2.0-85103127618